Trulieve Cannabis (TCNNF) Current Deferred Revenue (2020 - 2025)
Trulieve Cannabis has reported Current Deferred Revenue over the past 6 years, most recently at $9.6 million for Q4 2025.
- Quarterly results put Current Deferred Revenue at $9.6 million for Q4 2025, up 19.49% from a year ago — trailing twelve months through Dec 2025 was $9.6 million (up 19.49% YoY), and the annual figure for FY2025 was $9.6 million, up 19.49%.
- Current Deferred Revenue for Q4 2025 was $9.6 million at Trulieve Cannabis, up from $8.9 million in the prior quarter.
- Over the last five years, Current Deferred Revenue for TCNNF hit a ceiling of $9.6 million in Q4 2025 and a floor of $1.3 million in Q4 2023.
- Median Current Deferred Revenue over the past 5 years was $6.4 million (2022), compared with a mean of $6.2 million.
- Biggest five-year swings in Current Deferred Revenue: plummeted 85.89% in 2023 and later surged 501.35% in 2024.
- Trulieve Cannabis' Current Deferred Revenue stood at $6.7 million in 2021, then soared by 41.18% to $9.5 million in 2022, then plummeted by 85.89% to $1.3 million in 2023, then surged by 501.35% to $8.0 million in 2024, then rose by 19.49% to $9.6 million in 2025.
- The last three reported values for Current Deferred Revenue were $9.6 million (Q4 2025), $8.9 million (Q3 2025), and $8.4 million (Q2 2025) per Business Quant data.